HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Investments Streamline Supply Chain, Attract Industry Talent

This article was originally published in The Tan Sheet

Executive Summary

Herbalife’s “seed-to-feed” vertical integration strategy includes a $130 million facility in North Carolina to open in 2014 and the continued recruitment of dietary supplement scientific and regulatory experts. The multilevel marketer also is deploying novel modes of product distribution across its markets.

You may also be interested in...



Herbalife Pushes To Counter Pyramid Scheme Narrative

The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, in fact is essential in helping people lose weight and adopt healthy lifestyles, according to Herbalife executives.

Herbalife Shakes Off Market Dive After Investor Scare

David Einhorn’s questions during Herbalife’s Q1 earnings call sowed market doubt about the firm, whose stock dropped about 20% May 1. But analysts called the panic behind the sell-off “unwarranted” given the firm’s strong Q1 performance and sound fundamentals.

Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife

The dietary supplement industry lost one of its most active and vocal scientific leaders in Washington when Andrew Shao departed the Council for Responsible Nutrition for an executive post with Herbalife.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124387

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel